Valuation: DexCom, Inc.

Market Cap 2.75TCr 2.4TCr 2.21TCr 2.06TCr 3.91TCr 2,61800Cr 3.96TCr 27TCr 10TCr 1,28700Cr 10TCr 10TCr 4,43400Cr P/E 2026 *
29.1x
P/E 2027 * 24.4x
Enterprise Value 2.71TCr 2.37TCr 2.18TCr 2.03TCr 3.85TCr 2,57900Cr 3.91TCr 26TCr 10TCr 1,26800Cr 10TCr 9.95TCr 4,36900Cr EV / Sales 2026 *
5.18x
EV / Sales 2027 * 4.51x
Free-Float
93.34%
Yield 2026 *
-
Yield 2027 * -
1 day-0.32%
1 week+2.64%
Current month+5.07%
1 month-0.32%
3 months+15.61%
6 months+9.62%
Current year+9.08%
1 week 58.6
Extreme 58.6
62.4
1 month 58.6
Extreme 58.6
67.8
Current year 48.5
Extreme 48.5
67.8
1 year 46.88
Extreme 46.88
77.17
3 years 46.88
Extreme 46.88
131.88
5 years 46.88
Extreme 46.88
144.55
10 years 9.12
Extreme 9.125
144.55
Manager TitleAgeSince
Chief Executive Officer 47 01/01/2026
Director of Finance/CFO 46 19/03/2021
Chief Tech/Sci/R&D Officer - 01/05/2024
Director TitleAgeSince
Chairman 68 30/07/2018
Director/Board Member 67 20/11/2009
Director/Board Member 47 01/01/2026
Change 5-day change 1-year change 3-year change Capi.($)
-0.32%+2.64% - - 2.75TCr
+3.49%+1.36%-29.04%-11.02% 17TCr
+5.04%+2.73%-5.88%-4.53% 11TCr
+2.80%+3.63%+0.09%+55.31% 5.77TCr
+1.33%+1.39%+53.16%+49.84% 5.32TCr
+3.39%+1.39%-10.26%-39.65% 4.36TCr
+3.50%+11.11% - - 3.65TCr
+0.20%+4.24%+64.56%-3.33% 2.58TCr
+2.78%+1.17%-8.15%-0.43% 2.13TCr
+1.96%+2.08%-8.43%-1.27% 2.03TCr
Average +2.42%+3.98%+7.01%+5.61% 5.9TCr
Weighted average by Cap. +3.08%+3.35%-3.52%+3.40%

Financials

2026 *2027 *
Net sales 522.48Cr 456.75Cr 419.76Cr 391.26Cr 742.11Cr 50TCr 753.37Cr 5.04TCr 1.96TCr 24TCr 1.96TCr 1.92TCr 84TCr 582.95Cr 509.62Cr 468.34Cr 436.54Cr 828Cr 56TCr 840.56Cr 5.62TCr 2.19TCr 27TCr 2.19TCr 2.14TCr 94TCr
Net income 96Cr 84Cr 77Cr 72Cr 136.72Cr 9.16TCr 138.79Cr 928.38Cr 360.9Cr 4.51TCr 361.31Cr 353.55Cr 16TCr 115.77Cr 101.21Cr 93Cr 87Cr 164.44Cr 11TCr 166.93Cr 1.12TCr 434.08Cr 5.42TCr 434.56Cr 425.23Cr 19TCr
Net Debt -41Cr -35Cr -33Cr -30Cr -58Cr -3.86TCr -58Cr -390.65Cr -151.86Cr -1.9TCr -152.03Cr -148.77Cr -6.53TCr -121.13Cr -105.89Cr -97Cr -91Cr -172.05Cr -12TCr -174.66Cr -1.17TCr -454.16Cr -5.67TCr -454.67Cr -444.91Cr -20TCr
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
11,050
Date Price Change Volume
03/26/03 €62.20 -0.32% 0
02/26/02 €62.40 +3.31% 320
01/26/01 €60.40 +2.03% 0
30/26/30 €59.20 -2.95% 0
29/26/29 €61.00 +0.66% 36
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
71.25USD
Average target price
85.24USD
Spread / Average Target
+19.64%

Quarterly revenue - Rate of surprise